About this trial
The registry study aims to determine serial biomarkers to diagnosis and prognosis of aortic aneurysm/aortic dissection.
Eligibility criteria
Qualifiers
All patients who were referred to the surgical service for evaluation and management of aortic dissection were included.
Patients with initial suspicion of having AAD were perspectively enrolled.
Disqualifiers
Patients who received packed red blood cells, whole blood, or platelets less than 10 days before the blood sample was taken;
Patients with aortic trauma, pseudo aneurysm, history of heart failure, renal dysfunction, severe pulmonary diseases, or active cancer;
Patients who entered the hospital for checkups after surgery.
Patients in whom there is little or no suspicion of a life-threatening disease;
Trial design
Treatments tested in this trial
- Not listed
Trial groups
Sponsors and collaborators
Beijing Institute of Heart, Lung and Blood Vessel Diseases
Lead sponsor
Beijing Luhe Hospital
Collaborator
The First Affiliated Hospital of Dalian Medical University
Collaborator
The First Hospital of Jilin University
Collaborator
First Affiliated Hospital, Sun Yat-Sen University
Collaborator
The General Hospital of Northern Theater Command
Collaborator
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Collaborator